Search - tctmd.com

Displaying 81 - 100 of 849

Sort: Relevancy | Date

Presentation TCT 2017

TAVR in AS Patients With Acute Coronary Syndromes, Left Main Disease, and Coronary Access After TAVR: Case Examples and Procedural Techniques

Presenter: James B. Hermiller Jr.

November 01, 2017

Presentation TCT 2017

Transcatheter TR Solution 4: FORMA

Presenter: Francesco Maisano, Jason H. Rogers, John G. Webb

November 01, 2017

Presentation TCT 2017

TAVR in AS Patients With Stable Coronary Disease: Evolving Treatment Issues (When to Consider CABG, Timing of PCI, and Completeness of Revascularization)

Presenter: Torsten P. Vahl

November 01, 2017

Presentation TCT 2017

Shared Decision-making for PFO Closure: How to Make the FDA Requirements Work

Presenter: Lee N. Benson, Megan Coylewright

November 01, 2017

Presentation TCT 2017

Transcatheter TR Solution 3: MitraClip

Presenter: Francesco Maisano, Jason H. Rogers, Georg Nickenig

November 01, 2017

Presentation TCT 2017

SURTAVI Trial Critique and Unanswered Questions

Presenter: David J. Moliterno, Vinod H. Thourani, E. Murat Tuzcu

November 01, 2017

Presentation TCT 2017

The Role of MitraClip Therapy in TAVR Patients - Treatment Paradigms (Who, When, and How) and Case Examples

Presenter: Brij Maini

November 01, 2017

Presentation TCT 2017

Transcatheter TR Solution 2: Caval Valve Implantation

Presenter: Francesco Maisano, Jason H. Rogers, Hans R. Figulla

November 01, 2017

Presentation TCT 2017

SURTAVI: Topline Findings and Practice Implications

Presenter: David J. Moliterno, Vinod H. Thourani, Nicolas M. Van Mieghem

November 01, 2017

Presentation TCT 2017

Frequency of MR and Clinical Management Issues in TAVR Patients

Presenter: Marco Barbanti

November 01, 2017

Presentation TCT 2017

The PFO Clinic: Neurologists and Cardiologists as a Team

Presenter: Lee N. Benson, Megan Coylewright, Lars Sondergaard

November 01, 2017

Presentation TCT 2017

Transcatheter TR Solution 1: Trialign

Presenter: Francesco Maisano, Jason H. Rogers, Rebecca T. Hahn

November 01, 2017

Presentation TCT 2017

REPRISE III: Critique and Unanswered Questions

Presenter: David J. Moliterno, Vinod H. Thourani, Davide Capodanno

November 01, 2017

Presentation TCT 2017

Surgical Interventions for Functional Tricuspid Regurgitation: Guideline Indications, Risks, and Benefits

Presenter: Francesco Maisano, Jason H. Rogers, Gilles Dreyfus

November 01, 2017

Presentation TCT 2017

REPRISE III: Topline Findings and Practice Implications

Presenter: David J. Moliterno, Vinod H. Thourani, Ted Feldman

November 01, 2017

Presentation TCT 2017

Featured Lecture: Predictors of Mortality and Conduction Disturbances in Women Undergoing TAVR: A CT Sub-Analysis of the WIN-TAVI Registry

Presenter: Ariel Finkelstein, Ran Kornowski, Yusuke Watanabe

November 01, 2017

Presentation TCT 2017

Putting the Evidence Together: Updating Guidelines, Patient Selection, and Insurance Coverage III - FDA Perspective

Presenter: Robert J. Sommer, David L. Tirschwell, Andrew Farb

November 01, 2017

Presentation TCT 2017

TAVR in Asymptomatic Severe Aortic Stenosis: Updates From the EARLY TAVR Trial

Presenter: Ariel Finkelstein, Ran Kornowski, Philippe Genereux

November 01, 2017

Presentation TCT 2017

Putting the Evidence Together: Updating Guidelines, Patient Selection, and Insurance Coverage II - Patient Advocates Perspective

Presenter: Robert J. Sommer, David L. Tirschwell, Bray Patrick-Lake

November 01, 2017

Presentation TCT 2017

Who Are Reasonable (and Unreasonable) Candidates for Surgical or Transcatheter Intervention?

Presenter: Rebecca T. Hahn, Yan Topilsky

November 01, 2017

Advertisement

TAVR in AS Patients With Acute Coronary Syndromes, Left Main Disease, and Coronary Access After TAVR: Case Examples and Procedural Techniques

Transcatheter TR Solution 4: FORMA

TAVR in AS Patients With Stable Coronary Disease: Evolving Treatment Issues (When to Consider CABG, Timing of PCI, and Completeness of Revascularization)

Shared Decision-making for PFO Closure: How to Make the FDA Requirements Work

Transcatheter TR Solution 3: MitraClip

SURTAVI Trial Critique and Unanswered Questions

The Role of MitraClip Therapy in TAVR Patients - Treatment Paradigms (Who, When, and How) and Case Examples

Transcatheter TR Solution 2: Caval Valve Implantation

SURTAVI: Topline Findings and Practice Implications

Frequency of MR and Clinical Management Issues in TAVR Patients

The PFO Clinic: Neurologists and Cardiologists as a Team

Transcatheter TR Solution 1: Trialign

REPRISE III: Critique and Unanswered Questions

Surgical Interventions for Functional Tricuspid Regurgitation: Guideline Indications, Risks, and Benefits

REPRISE III: Topline Findings and Practice Implications

Featured Lecture: Predictors of Mortality and Conduction Disturbances in Women Undergoing TAVR: A CT Sub-Analysis of the WIN-TAVI Registry

Putting the Evidence Together: Updating Guidelines, Patient Selection, and Insurance Coverage III - FDA Perspective

TAVR in Asymptomatic Severe Aortic Stenosis: Updates From the EARLY TAVR Trial

Putting the Evidence Together: Updating Guidelines, Patient Selection, and Insurance Coverage II - Patient Advocates Perspective

Who Are Reasonable (and Unreasonable) Candidates for Surgical or Transcatheter Intervention?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content